This paper summarized Professor PI Chiheng's experience in treating diabetic nephropathy （DN） using the method of warming yang， nourishing yin， and invigorating blood by stages. It is believed that yang deficiency and yin depletion are the key pathological mechanisms of DN， with blood stasis running throughout the disease's progression. The general treatment principle is to warm yang， nourish yin， and invigorate blood， with different emphases at each stage. For early stage， the disease is characterized by spleen qi deficiency and insufficiency of qi and yin， which could be treated by modified Shenqi Dihuang Decoction （参芪地黄汤） to tonify qi and invigorate blood， strengthen yang and consolidate yin； for middle stage， the disease is marked by spleen and kidney yang deficiency with internal dampness accumulation， which could be treated by modified Zhenwu Decoction （真武汤） and Sanren Decoction （三仁汤） warming yang and to resolve dampness and unblock meridians； for the late stage， the disease is characterized by blood stasis and toxin accumulation with deficiency of both yin and yang， which could be treated by modified Jisheng Shenqi Pill （济生肾气丸） to eliminate pathological masses and remove toxins， warm yang and nourish yin. Additionally， traditional Chinese medicine therapies such as rubbing with ointment （Gao Mo therapy） are utilized as adjunct treatments， treating the root and branch simultaneously and combining internal and external approaches.

This paper summarized Professor HAN Mingxiang's clinical experience in treating insomnia in the elderly based on the theory of “deficiency leading to stasis”. It is believed that the core pathogenesis of insomnia in the elderly lies in the weakness of the zang-fu （脏腑） organs and the obstruction of the heart vessel. He advocates the basic treatment principles of supplementing deficiency and dispelling stasis， calming the heart and mind. For insomnia in the elderly with a pattern of heart-spleen deficiency， modified Buyang Huanwu Decoction （补阳还五汤） and Guipi Decoction （归脾汤） could be prescribed to tonify qi， nourish blood， and calm the heart and spirit. For pattern of liver-kidney yin deficiency， modified Qiju Dihuang Decoction （杞菊地黄汤） and Suanzaoren Decoction （酸枣仁汤） could be prescribed to nourish yin， clear heat， cool blood， and tranquilize mind. For pattern of kidney yang deficiency， modified Yougui Pill （右归丸） and Taohong Siwu Decoction （桃红四物汤） could be prescribed to warm yang， dispel cold， eliminate stagnation， and tranquilize the spirit. For pattern of phlegm-dampness stagnation， Xuefu Zhuyu Decoction （血府逐瘀汤） and Wendan Decoction （温胆汤） could be prescribed to resolve phlegm， dispel dampness， eliminate stagnation， and tranquilize the mind.

Objective To investigate the effect of intrarectal local anesthesia (IRLA) with heated oxybuprocaine gel on pain during transrectal ultrasound guided prostate biopsy (TRUSPB).Methods A total of 150 cases patients who underwent TRUSPB in Huzhou Central Hospital from January to June 2023 were prospectively taken into.The patients were randomly divided into group A (routine group),group B (oxybuprocaine gel for IRLA at room temperature) and group C (oxybuprocaine gel for IRLA at 40℃),with 50 cases in each group.Nurses who were unaware of the anesthesia type used visual analog scale (VAS) to score the pain level of patients at each stage (VAS Ⅰ:when the ultrasound probe was inserted into the rectum;VAS Ⅱ:during the biopsy;VAS Ⅲ:30 minutes after biopsy),and the incidence of complications after biopsy were compared.Results The VAS Ⅱ score of group C was lower than that of group A and group B,and the difference was statistically significant (P<0.05).There was no statistically significant difference (P>0.05) in the VAS Ⅰ,VAS Ⅲ scores,and incidence of complications after biopsy among the three groups.There was no allergic reaction to oxybuprocaine gel.Conclusion In TRUSPB,IRLA with heated oxybuprocaine gel can effectively control pain without increasing incidence of complications.

Objectives:To explore the curative effect of posterior lumbar interbody fusion under Delta large channel endoscope(Endo-PLIF)on degenerative lumbar diseases.Methods:A retrospective analysis was per-formed on the case data of 80 patients with degenerative lumbar diseases treated in the hospital between September 2021 and September 2022.The patients were divided into observation group(38 cases,17 males and 21 females,aged 61.0±4.9 years)and control group(42 cases,20 males and 22 females,aged 60.5±5.4 years).The patients in the observation group were treated with Endo-PLIF,while those in the control group were treated with open posterior lumbar interbody fusion.The intraoperative blood loss,postoperative drainage volume,operative time,length of surgical incisions,length of hospital stays,and complications of both groups of patients were recorded and compared.The visual analogue scale(VAS)was used to evaluate patients'low back pain and Oswestry disability index(ODI)was used to assess the lumbar function before surgery,at 1 week,1 month,3 months and 6 months after surgery.The patients were also evaluated using the modified Macnab criteria for treatment efficacy,and using the Bridwell criteria for assessing the segmental fusion within 1 year after surgery.Results:The intraoperative blood loss and postoperative drainage volume in the observation group were 88.46±10.98mL and 159.73±18.42mL,lower than those in the control group 112.99±12.01mL and 201.36±23.06mL(P＜0.05);The lengths of surgical incision and hospital stays were 1.54±0.36cm and 6.79±1.22d,which were shorter in the observation group than those in the control group of 5.43±1.01cm and 8.03±1.43d(P＜0.05);And the operative time was longer in the observation group than that in the control group(162.33±19.57min vs 126.87±23.15min,P＜0.05).All the patients were followed up for 15-40 months(19.0±6.3 months).At 1 week and 1 month after surgery,VAS scores in observation group were 2.46±0.51 and 1.21±0.38,and ODI were(17.84±4.15)％and(10.69±1.88)％,which were lower than those in the control group[VAS score:3.68±0.62,2.01±0.41;ODI:(21.33±3.48)％,(12.33±2.17)％,P＜0.05].At 3 months and 6 months after surgery,there was no significant difference in VAS scores between the two groups(P＞0.05).There was neither significant difference in the excellent and good rate of treatment(92.11％vs 85.71％,P=0.487)nor significant difference in fusion grading between the observation group and control group(Z=0.487,P=0.624).No significant difference was noticed in the incidence of postoperative complications between observation group and control group(5.26％vs 9.52％,P=0.678).Conclusions:The curative effect of Endo-PLIF is satisfactory on degenerative lumbar diseases,which can reduce intraoperative blood loss,shorten surgical incision and hospitalization time,improve short-term pain and lumbar function faster,with good safety.

Objective To monitor the susceptibility of clinical isolates to antimicrobial agents in tertiary hospitals in major regions of China in 2022.Methods Clinical isolates from 58 hospitals in China were tested for antimicrobial susceptibility using a unified protocol based on disc diffusion method or automated testing systems.Results were interpreted using the 2022 Clinical &Laboratory Standards Institute(CLSI)breakpoints.Results A total of 318 013 clinical isolates were collected from January 1,2022 to December 31,2022,of which 29.5％were gram-positive and 70.5％were gram-negative.The prevalence of methicillin-resistant strains in Staphylococcus aureus,Staphylococcus epidermidis and other coagulase-negative Staphylococcus species(excluding Staphylococcus pseudintermedius and Staphylococcus schleiferi)was 28.3％,76.7％and 77.9％,respectively.Overall,94.0％of MRSA strains were susceptible to trimethoprim-sulfamethoxazole and 90.8％of MRSE strains were susceptible to rifampicin.No vancomycin-resistant strains were found.Enterococcus faecalis showed significantly lower resistance rates to most antimicrobial agents tested than Enterococcus faecium.A few vancomycin-resistant strains were identified in both E.faecalis and E.faecium.The prevalence of penicillin-susceptible Streptococcus pneumoniae was 94.2％in the isolates from children and 95.7％in the isolates from adults.The resistance rate to carbapenems was lower than 13.1％in most Enterobacterales species except for Klebsiella,21.7％-23.1％of which were resistant to carbapenems.Most Enterobacterales isolates were highly susceptible to tigecycline,colistin and polymyxin B,with resistance rates ranging from 0.1％to 13.3％.The prevalence of meropenem-resistant strains decreased from 23.5％in 2019 to 18.0％in 2022 in Pseudomonas aeruginosa,and decreased from 79.0％in 2019 to 72.5％in 2022 in Acinetobacter baumannii.Conclusions The resistance of clinical isolates to the commonly used antimicrobial agents is still increasing in tertiary hospitals.However,the prevalence of important carbapenem-resistant organisms such as carbapenem-resistant K.pneumoniae,P.aeruginosa,and A.baumannii showed a downward trend in recent years.This finding suggests that the strategy of combining antimicrobial resistance surveillance with multidisciplinary concerted action works well in curbing the spread of resistant bacteria.

Objective To investigate the distribution and antimicrobial resistance profiles of the common pathogens isolated from urine from 2015 to 2021 in the CHINET Antimicrobial Resistance Surveillance Program.Methods The bacterial strains were isolated from urine and identified routinely in 51 hospitals across China in the CHINET Antimicrobial Resistance Surveillance Program from 2015 to 2021.Antimicrobial susceptibility was determined by Kirby-Bauer method,automatic microbiological analysis system and E-test according to the unified protocol.Results A total of 261 893 nonduplicate strains were isolated from urine specimen from 2015 to 2021,of which gram-positive bacteria accounted for 23.8％(62 219/261 893),and gram-negative bacteria 76.2％(199 674/261 893).The most common species were E.coli(46.7％),E.faecium(10.4％),K.pneumoniae(9.8％),E.faecalis(8.7％),P.mirabilis(3.5％),P.aeruginosa(3.4％),SS.agalactiae(2.6％),and E.cloacae(2.1％).The strains were more frequently isolated from inpatients versus outpatients and emergency patients,from females versus males,and from adults versus children.The prevalence of ESBLs-producing strains in E.coli,K.pneumoniae and P.mirabilis was 53.2％,52.8％and 37.0％,respectively.The prevalence of carbapenem-resistant strains in E.coli,K.pneumoniae,P.aeruginosa and A.baumannii was 1.7％,18.5％,16.4％,and 40.3％,respectively.Lower than 10％of the E.faecalis isolates were resistant to ampicillin,nitrofurantoin,linezolid,vancomycin,teicoplanin and fosfomycin.More than 90％of the E.faecium isolates were ressitant to ampicillin,levofloxacin and erythromycin.The percentage of strains resistant to vancomycin,linezolid or teicoplanin was＜2％.The E.coli,K.pneumoniae,P.aeruginosa and A.baumannii strains isolated from ICU inpatients showed significantly higher resistance rates than the corresponding strains isolated from outpatients and non-ICU inpatients.Conclusions E.coli,Enterococcus and K.pneumoniae are the most common pathogens in urinary tract infection.The bacterial species and antimicrobial resistance of urinary isolates vary with different populations.More attention should be paid to antimicrobial resistance surveillance and reduce the irrational use of antimicrobial agents.

Objective To understand the distribution and changing resistance profiles of clinical isolates of Enterococcus in hospitals across China from 2015 to 2021.Methods Antimicrobial susceptibility testing was conducted for the clinical isolates of Enterococcus according to the unified protocol of CHINET program by automated systems,Kirby-Bauer method,or E-test strip.The results were interpreted according to the Clinical & Laboratory Standards Institute(CLSI)breakpoints in 2021.WHONET 5.6 software was used for statistical analysis.Results A total of 124 565 strains of Enterococcus were isolated during the 7-year period,mainly including Enterococcus faecalis(50.7％)and Enterococcus faecalis(41.5％).The strains were mainly isolated from urinary tract specimens(46.9％±2.6％),and primarily from the patients in the department of internal medicine,surgery and ICU.E.faecium and E.faecalis strains showed low level resistance rate to vancomycin,teicoplanin and linezolid(≤3.6％).The prevalence of vancomycin-resistant E.faecalis and E.faecium was 0.1％and 1.3％,respectively.The prevalence of linezolid-resistant E.faecalis increased from 0.7％in 2015 to 3.4％in 2021,while the prevalence of linezolid-resistant E.faecium was 0.3％.Conclusions The clinical isolates of Enterococcus were still highly susceptible to vancomycin,teicoplanin,and linezolid,evidenced by a low resistance rate.However,the prevalence of linezolid-resistant E.faecalis was increasing during the 7-year period.It is necessary to strengthen antimicrobial resistance surveillance to effectively identify the emergence of antibiotic-resistant bacteria and curb the spread of resistant pathogens.

Objective To examine the changing antimicrobial resistance profile of Enterobacter spp.isolates in 53 hospitals across China from 2015 t0 2021.Methods The clinical isolates of Enterobacter spp.were collected from 53 hospitals across China during 2015-2021 and tested for antimicrobial susceptibility using Kirby-Bauer method or automated testing systems according to the CHINET unified protocol.The results were interpreted according to the breakpoints issued by the Clinical & Laboratory Standards Institute(CLSI)in 2021(M100 31st edition)and analyzed with WHONET 5.6 software.Results A total of 37 966 Enterobacter strains were isolated from 2015 to 2021.The proportion of Enterobacter isolates among all clinical isolates showed a fluctuating trend over the 7-year period,overall 2.5％in all clinical isolates amd 5.7％in Enterobacterale strains.The most frequently isolated Enterobacter species was Enterobacter cloacae,accounting for 93.7％(35 571/37 966).The strains were mainly isolated from respiratory specimens(44.4±4.6)％,followed by secretions/pus(16.4±2.3)％and urine(16.0±0.9)％.The strains from respiratory samples decreased slightly,while those from sterile body fluids increased over the 7-year period.The Enterobacter strains were mainly isolated from inpatients(92.9％),and only(7.1±0.8)％of the strains were isolated from outpatients and emergency patients.The patients in surgical wards contributed the highest number of isolates(24.4±2.9)％compared to the inpatients in any other departement.Overall,≤ 7.9％of the E.cloacae strains were resistant to amikacin,tigecycline,polymyxin B,imipenem or meropenem,while ≤5.6％of the Enterobacter asburiae strains were resistant to these antimicrobial agents.E.asburiae showed higher resistance rate to polymyxin B than E.cloacae(19.7％vs 3.9％).Overall,≤8.1％of the Enterobacter gergoviae strains were resistant to tigecycline,amikacin,meropenem,or imipenem,while 10.5％of these strains were resistant to polycolistin B.The overall prevalence of carbapenem-resistant Enterobacter was 10.0％over the 7-year period,but showing an upward trend.The resistance profiles of Enterobacter isolates varied with the department from which they were isolated and whether the patient is an adult or a child.The prevalence of carbapenem-resistant E.cloacae was the highest in the E.cloacae isolates from ICU patients.Conclusions The results of the CHINET Antimicrobial Resistance Surveillance Program indicate that the proportion of Enterobacter strains in all clinical isolates fluctuates slightly over the 7-year period from 2015 to 2021.The Enterobacter strains showed increasing resistance to multiple antimicrobial drugs,especially carbapenems over the 7-year period.